Gynodian® Depot (BAY86-5032) + BAY86-4980
Phase 3Completed 0 watching 0 views this week📈 Rising
74
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Hormone Replacement Therapy
Conditions
Hormone Replacement Therapy
Trial Timeline
May 1, 2002 → Apr 1, 2004
NCT ID
NCT00463450About Gynodian® Depot (BAY86-5032) + BAY86-4980
Gynodian® Depot (BAY86-5032) + BAY86-4980 is a phase 3 stage product being developed by Bayer for Hormone Replacement Therapy. The current trial status is completed. This product is registered under clinical trial identifier NCT00463450. Target conditions include Hormone Replacement Therapy.
Hype Score Breakdown
Clinical
27
Activity
18
Company
7
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00463450 | Phase 3 | Completed |
Competing Products
20 competing products in Hormone Replacement Therapy